Changes in plasma and urinary tryptophan in chronic renal failure
Ma, J.M.; Zhu, H.W.; Chen, W.Y.
Zhonghua Nei Ke Za Zhi 27(3): 153-6 197
1988
ISSN/ISBN: 0578-1426 PMID: 3219931 Document Number: 315653
Document emailed within 1 workday
Related Documents
Fukuda, S.; Kobayashi, H.; Mochizuki, T.; Tanaka, M.; Yokoyama, Y.; Hattori, N. 1992: Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure Nihon Jinzo Gakkai Shi 34(9): 1011-1017Zhu, J.; Xiong, X.; Zhao, S.; Wang, Z.; Lou, L.; Hang, Q. 1999: Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure Hunan Yi Ke da Xue Xue Bao 24(4): 366-368
Chen, J.H.; Tsai, J.H.; Lai, Y.H.; Hwang, S.J. 1990: Plasma atrial natriuretic peptide in patients with chronic renal failure Journal of the Formosan Medical Association 89(8): 645-650
Szczepańska, M.; Szprynger, K.; Mazur, B.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Makulska, I. 2007: Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(1): 61-66
Li, J.-l.; Zheng, F.-l.; Tan, H.-b.; Yin, S.-y.; Yang, J.-h.; Li, Y.; Bu, Y.-f. 2003: Orexin a and neuropeptide y levels in plasma and hypothalamus of rats with chronic renal failure Zhonghua Yi Xue Za Zhi 83(11): 992-995
Bower, S. 1982: Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure Journal of Pharmacy and Pharmacology 34(2): 102-106
Caravaca, F.; Ruiz, A.B.; Escola, J.M.; Hernández Gallego, R.; Cerezo, I.; Fernández, N.; Barroso, S.; Martín, M.V. 2007: Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(4): 466-471
Allman, M.A.; Pang, E.; Yau, D.F.; Stewart, P.M.; Tiller, D.J.; Truswell, A.S. 1992: Elevated plasma vitamers of vitamin B6 in patients with chronic renal failure on regular haemodialysis European Journal of Clinical Nutrition 46(9): 679-683
Caimi, G. 2002: Erythrocyte peroxide metabolism, plasma lipid pattern and hemorheological profile in chronic renal failure Journal of Nephrology 15(2): 104-108
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473
Chauveau, P.; Chadefaux, B.; Coudé, M.; Aupetit, J.; Kamoun, P.; Jungers, P. 1996: Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure Mineral and Electrolyte Metabolism 22(1-3): 106-109
Lambert, P.W.; DeOreo, P.B.; Hollis, B.W.; Fu, I.Y.; Ginsberg, D.J.; Roos, B.A. 1981: Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects Journal of Laboratory and Clinical Medicine 98(4): 536-548
Korczyńska, J.; Stelmańska, E.; Nieweglowski, T.; Szołkiewicz, M.; Rutkowski, B.; Swierczyński, J. 2000: Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure Polish Journal of Pharmacology 52(4): 291-297
Stegmayr, B.G.; Jakobson, S.; Rydvall, A.; Björsell-Ostling, E. 1995: Plasma exchange in patients with acute renal failure in the course of multiorgan failure International Journal of Artificial Organs 18(1): 45-52
Koide, K.; Sano, M.; Morio, K.; Takeda, F.; Ubukata, E.; Momose, T.; Toyama, J.; Sudo, M.; Inoue, N.; Koshikawa, S. 1987: Clinical course of beta 2-microglobulin in the plasma of patients suffering from chronic renal failure under conservative therapy in relation to oral adsorbent therapy Nihon Jinzo Gakkai Shi 29(11): 1421-1428
Bohle, A.; Müller, G.A.; Wehrmann, M.; Mackensen-Haen, S.; Xiao, J.C. 1996: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides Kidney International. Suppl 54: S2-S9
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
González, F. 2003: Implementation of AUGE plan for chronic renal failure patients. The implementation of Universal Access and Explicit Guaranties Plan (AUGE), generates longer waiting lists among patients with chronic renal failure Revista Medica de Chile 131(5): 545-551
Adams, L.G.; Polzin, D.J.; Osborne, C.A.; O'Brien, T.D. 1991: Comparison of fractional excretion and 24-hour urinary excretion of sodium and potassium in clinically normal cats and cats with induced chronic renal failure American Journal of Veterinary Research 52(5): 718-722
Otokida, K.; Fujiwara, T.; Oriso, S.; Kato, M. 1989: Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF Nihon Jinzo Gakkai Shi 31(6): 651-656